These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24819973)

  • 1. Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder.
    Kagawa S; Mihara K; Nakamura A; Nemoto K; Suzuki T; Nagai G; Kondo T
    Ther Drug Monit; 2014 Dec; 36(6):730-3. PubMed ID: 24819973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2.
    Nakamura A; Mihara K; Nagai G; Kagawa S; Suzuki T; Nemoto K; Kondo T
    Ther Drug Monit; 2016 Jun; 38(3):379-82. PubMed ID: 26829597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
    Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy.
    Suzuki T; Mihara K; Nagai G; Kagawa S; Nakamura A; Nemoto K; Kondo T
    Ther Drug Monit; 2019 Feb; 41(1):86-90. PubMed ID: 30489548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Partial Response at Week 4 Can Predict Subsequent Outcome during Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder: A Preliminary Study.
    Nagai G; Mihara K; Kagawa S; Nakamura A; Suzuki T; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 76(4):187-192. PubMed ID: 29961057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A High Plasma Lamotrigine Concentration at Week 2 as a Risk Factor for Lamotrigine-Related Rash.
    Suzuki T; Mihara K; Nagai G; Kagawa S; Nakamura A; Nemoto K; Kondo T
    Ther Drug Monit; 2020 Aug; 42(4):631-635. PubMed ID: 31985552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy.
    Tomori Y; Suzuki T; Mihara K; Nagai G; Kagawa S; Nakamura A; Nemoto K; Kondo T
    Clin Neuropharmacol; 2024 Sep-Oct 01; 47(5):163-167. PubMed ID: 39171842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the Efficacy of Lamotrigine and the Serum Lamotrigine Level during the Remission Phase of Acute Bipolar II Depression: A Naturalistic and Unblinded Prospective Pilot Study.
    Kikkawa A; Kitamura Y; Aiba T; Hiraki K; Sendo T
    Biol Pharm Bull; 2017; 40(4):413-418. PubMed ID: 28381796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.
    Schindler F; Anghelescu IG
    Int Clin Psychopharmacol; 2007 May; 22(3):179-82. PubMed ID: 17414745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    Manning JS; Haykal RF; Connor PD; Cunningham PD; Jackson WC; Long S
    J Affect Disord; 2005 Feb; 84(2-3):259-66. PubMed ID: 15708424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A factor analytic study in bipolar depression, and response to lamotrigine.
    Mitchell PB; Hadzi-Pavlovic D; Evoniuk G; Calabrese JR; Bowden CL
    CNS Spectr; 2013 Aug; 18(4):214-24. PubMed ID: 23702258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine adjunctive treatment in resistant unipolar depression: an open, descriptive study.
    Gabriel A
    Depress Anxiety; 2006; 23(8):485-8. PubMed ID: 16845646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression].
    Krawczyk K; Rybakowski J
    Psychiatr Pol; 2012; 46(4):585-98. PubMed ID: 23214161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant monotherapy compared with combinations of antidepressants in the treatment of resistant depressive patients: a randomized, open-label study.
    Bares M; Novak T; Kopecek M; Stopkova P; Cermak J; Kozeny J; Höschl C
    Int J Psychiatry Clin Pract; 2013 Feb; 17(1):35-43. PubMed ID: 22486580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
    Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA
    Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
    Chang JS; Moon E; Cha B; Ha K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interaction between sertraline and lamotrigine in psychiatric patients: a retrospective study.
    Christensen J; Sandgaard AP; Sidenius P; Linnet K; Licht RW
    Pharmacopsychiatry; 2012 May; 45(3):119-21. PubMed ID: 22426846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.